Home » Topics » Disease categories and therapies » Immune

Immune
RSS

EQiTX restructures synthetic vaccine project

July 6, 2006

RotaTeq approved in Europe

July 4, 2006

Astellas discontinues development of immunosuppressant FK-778

July 3, 2006

Pooled data suggest heptavalent DTPw-HBV/Hib-MenAC vaccine is safe

June 30, 2006

New orphan drug designations for rhC1INH

June 15, 2006

Neumune cleared for clinical study in patients at risk of nosocomial infections

June 13, 2006

Enrollment completed ahead of schedule in ragweed allergy trial of Tolamba

June 12, 2006

Orphan drug designation for CellCept for pemphigus vulgaris

June 9, 2006

Rotarix launched in U.K.

June 1, 2006

ImmuFact IMP-321 completes phase I studies

June 1, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...